Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1CNS 1

Conditions

Hodgkin Disease 18Lymphoma 12Urinary Bladder Neoplasms 5Melanoma 5Leukemia 2Skin Neoplasms 1Sarcoma 1Rhabdoid Tumor 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1HIV Infections 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma 1Bladder Adenocarcinoma 1

Interventions

trametinib 1tipifarnib 1pirfenidone 1peginterferon alfa-2b 1nilotinib 1mirdametinib 1dabrafenib 1cediranib 1cabozantinib 1binimetinib 1Vinblastine 1Surveys and Questionnaires 1Methotrexate 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Everolimus 1Acceptance and Commitment Therapy 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neurofibroma, Plexiform × Vinblastine × Clear all
NCT00030264 2018-08-08

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

Children's Hospital of Philadelphia

Phase 2 Completed
23 enrolled 9 charts
CNSOther neoplasm

Neurofibromatosis 1, Precancerous Conditions, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡